Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
D000368:Aged; D002624:Chemistry, Clinical; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D002537:Intracranial Arteriosclerosis / Q000134:cerebrospinal fluid; D008297:Male; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000494:pharmacology*
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid